AlveoliX AG Revenue and Competitors

Bern,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AlveoliX AG's estimated annual revenue is currently $2.5M per year.(i)
  • AlveoliX AG's estimated revenue per employee is $155,000

Employee Data

  • AlveoliX AG has 16 Employees.(i)
  • AlveoliX AG grew their employee count by -11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is AlveoliX AG?

Our Vision We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs' responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing. Our Mission AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AlveoliX AG News

2022-04-06 - Die Finalisten des Swiss Medtech Awards stehen fest

Alveolix AG – Lung-on-Chip System zur Verbesserung der Arzneimittelentwicklung: Das Berner Start-up hat sich zum Ziel gesetzt,...

2022-04-06 - Healios AG Named as a Finalist for the Coveted 2022 Swiss ...

Additionally, we are proud to share in celebrating this achievement with fellow finalists, AlveoliX AG and Biospectal SA,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M16-30%N/A
#2
$2.2M186%N/A
#3
$3.7M1912%N/A
#4
N/A19-10%N/A
#5
$1.7M24N/AN/A